09886 DINGDANG HEALTH
- 1.220
- +0.070+6.09%
DINGDANG HEALTH News
叮噹健康：2023年年度報告
Dingdang Health Technology Slashes Losses in 2023
Dingdang Health Technology Group's (HKG:9886) net loss narrowed by 91.9% to 230.9 million yuan in 2023, from a loss of about 2.84 billion yuan in the previous year, according to a March. 28 filing wit
Dingdang Health (09886) released annual results. The adjusted net loss of 107 million yuan narrowed 17.2% year over year
According to Zhitong Finance App News, Dingdang Health (09886) announced its annual results for the year ended December 31, 2023. The group obtained revenue of RMB 4.857 billion (same unit), an increase of 12.2% year over year; company owners should have accounted for losses of RMB 226 million during the year, a decrease of 92% year over year; adjusted net loss of RMB 107 million, a decrease of 17.2% year on year; loss per share. In the year ended December 31, 2023, the company's total revenue increased to 4.857 billion yuan (2022:4.329 billion yuan), an increase of 12.2% over the previous year; registered users and healthcare
DINGDANG HEALTH: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
Dingdang Health (09886.HK) plans to hold a board meeting on March 28 to approve annual results
Glonghui, March 18, 丨 Dingdang Health (09886.HK) announced that the company is pleased to hold a board meeting on March 28, 2024 (Thursday) to review and approve the Group's annual results and publication for the year ended 31 December 2023, and to consider the proposed payment of a final dividend (if any).
Gelonghui Announcement Selection (Hong Kong Stock) | Baidu Group - SW (09888.HK): Total revenue of 134.6 billion yuan for fiscal year 2023 increased 9% year over year
[Today's Focus] Baidu Group - SW (09888.HK): Total revenue for fiscal year 2023 of 134.6 billion yuan, up 9% year on year Baidu Group - SW (09888.HK) announced that for fiscal year 2023, total revenue was RMB 134.6 billion (US$18.96 billion), up 9% year on year. Baidu's core revenue was RMB 103.5 billion (US$14.57 billion), up 8% year on year; online marketing revenue was RMB 75.1 billion (US$10.58 billion), up 8% year over year, and non-online marketing revenue was RMB 28.4 billion (39.9 billion yen)
Dingdang Health (09886.HK) performance forecast: Annual losses are expected to narrow by more than 85% year on year
Glonghui, Feb. 28, 丨 Dingdang Health (09886.HK) announced that based on a preliminary assessment of the Group's unaudited comprehensive management accounts for the year ended 31 December 2023 (“FY2023”), the Group expects that due to (i) the completion of the listing of the company's shares on the Stock Exchange of Hong Kong Limited in September 2022, there will be no more preferred shares of the company (which are shares issued to investors before the company's initial public offering) as fair value losses and listing expenses of financial liabilities recorded at a fair value, and (ii) the 2023 finance Annual share-based payments
DINGDANG HEALTH: PROFIT ALERT - NARROWING OF LOSS
Dingdang Health (09886) fell 2.80% and now reports 1.440 yuan, a 52-week low
As of 16:08, Dingdang Health (09886) is down 2.80% from yesterday's closing price. It now reports a 52-week low of $1.440; the trading volume is 506,500 shares, with a turnover of HK$736,500.
Health services warm people's hearts, and health was awarded “2023 Outstanding Corporate ESG Social Responsibility Practice Case” by Xinhuanet
Recently, the 2023 Boao Forum for Chinese Entrepreneurs was held in Boao, Hainan. This year's Boao Forum was co-hosted by Xinhua News Agency, the Hainan Provincial People's Government, the China Brand Building Promotion Association, the Xinhua News Agency Brand Work Office, Xinhuanet, and the Hainan Provincial Committee of the China Council for the Promotion of Trade. At the conference sub-forum “ESG Practice in China Seminar”, Dingdang Health was selected as the “2023 Enterprise ESG Outstanding Social Responsibility Practice Case” by Xinhuanet for its practical exploration of digital technology in meeting the needs of public medication and health services. According to information, as an immediate health delivery service company, Dingdang Health aims to establish a “medical examination”
Dingdang Health Technology Group Ltd.'s (HKG:9886) Stock Price Dropped 16% Last Week; Private Companies Would Not Be Happy
Key Insights Dingdang Health Technology Group's significant private companies ownership suggests that the key decisions are influenced by shareholders from the larger public A total of 4 investors h
Doraemon Health (09886.HK) appoints Liu Zhenxuan as Joint Company Secretary
Glonghui September 29丨Dingdang Health (09886.HK) announced that Mr. Wang Yongzhi resigned as the company's joint company secretary due to his intention to focus on other matters, effective from September 30, 2023. After Mr. Yu Wang resigned as Joint Company Secretary, Mr. Liu Zhenxuan has been appointed as Joint Company Secretary, effective September 30, 2023. Mr. Lin Xiaobo will continue to serve as another joint company secretary.
DINGDANG HEALTH: INTERIM REPORT 2023
Dingdang Health (09886): Yang Yibin appointed as Executive Director
Zhitong Financial App News, DingDang Health (09886) announced that Yang Yibin has been appointed as an executive director, effective from August 25, 2023.
DINGDANG HEALTH: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023
AI Doctors Take Headache Out of Visits
Ten years ago, when someone wanted to see a doctor in China, they needed to wait in long lines in hospitals to get a number, check in at a nurse station, and then wait to see an available physician.
Doraemon Health (09886.HK) will hold a board meeting on August 25 to approve interim results
Glonway August 14, 丨Dingbang Health (09886.HK) announced that the company will hold a board meeting on August 25, 2023 to review and approve the Group's interim results and publication for the six months ended June 30, 2023, and consider the payment of interim dividends (if any).
DINGDANG HEALTH: DATE OF BOARD MEETING
Dingdang Health Expects H1 Net Loss to Narrow Up to 70%; Shares Decline 3%
Dingdang Health Technology (HKG:9886) expects its net loss to narrow by more than 70% in the first half from 586 million yuan in the year-ago period, a Wednesday filing said. The decline in net loss i
Doraemon Health (09886) earnings alert expects net loss in the first half of the year to narrow by more than 70% year on year
According to the Zhitong Finance App, Dingdang Health (09886) announced that since the listing of the company's shares on the Hong Kong Stock Exchange Limited in September 2022 is completed, the group expects that after the listing of the company's shares on the Hong Kong Stock Exchange Limited in September 2022, there will be no more of the company's priority shares (which are preferred shares issued to investors before the initial public offering) as fair value losses and listing expenses as fair value financial liabilities included in fair value, and share-based payments may be reduced by 70% or more during this period.
Analysis
Price Target
No Data
